臨床泌尿器科70巻1号

2016年01月発行

特集 決定版! 過活動膀胱─All about OAB

〈診断〉

過活動膀胱の尿中バイオマーカー

著者： 原綾英¹ 横山光彦² 永井敦¹

所属機関： ¹川崎医科大学泌尿器科 ²よこやま腎泌尿器クリニック

ページ範囲：P.30 - P.34

文献概要

ポイント

・OABの尿中バイオマーカーのなかで，最も研究がされているのがNGFである．

・いまだ確立されたOABの尿中バイオマーカーはない．

・尿中バイオマーカーは，OABの治療効果判定および補助診断に活用できる可能性がある．

参考文献

1） 日本排尿機能学会 過活動膀胱診療ガイドライン作成委員会（編） : 過活動膀胱診療ガイドライン 第2版. pp91─101, リッチヒルメディカル, 東京, 2015

2） Nomiya M, Sagawa K, Yazaki J, et al : Increased bladder activity is associated with elevated oxidative stress markers and proinflammatory cytokines in a rat model of atherosclerosis-induced chronic bladder ischemia. Neurourol Urodyn 31 : 185─189, 2012

3） Levi-Montalcini R and Calissano P : The nerve-growth factor. Sci Am 240 : 68─77, 1979

4） Lee SR, Hong CH, Choi YD, et al : Increased urinary nerve growth factor as a predictor of persistent detrusor overactivity after bladder outlet obstruction relief in a rat model. J Urol 183 : 2440─2444, 2010

5） Liu HT, Chen CY and Kuo HC : Urinary nerve growth factor in women with overactive bladder syndrome. BJU Int 107 : 799─803, 2011

6） Liu HT, Chancellor MB and Kuo HC : Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder. BJU Int 103 : 1668─1672, 2009

7） Aydoğmuş Y, Sunay M, Arslan H, et al : Acupuncture versus solifenacin for treatment of overactive bladder and its correlation with urine nerve growth factor levels : a randomized, placebo-controlled clinical trial. Urol Int 93 : 437─443, 2014

8） Liu HT, Chancellor MB and Kuo HC : Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur Urol 56 : 700─706, 2009

9） Yokoyama T, Kumon H and Nagai A : Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder. Neurourol Urodyn 27 : 417─420, 2008

10） Pinto R, Frias B, Allen S, et al : Sequestration of brain derived nerve factor by intravenous delivery of TrkB-Ig2 reduces bladder overactivity and noxious input in animals with chronic cystitis. Neuroscience 166 : 907─916, 2010

11） Antunes-Lopes T, Pinto R, Barros SC, et al : Urinary neurotrophic factors in healthy individuals and patients with overactive bladder. J Urol 189 : 359─365, 2013

12） Wang LW, Han XM, Chen CH, et al : Urinary brain-derived neurotrophic factor : a potential biomarker for objective diagnosis of overactive bladder. Int Urol Nephrol 46 : 341─347, 2014

13） Bhide AA, Cartwright R, Khullar V, et al : Biomarkers in overactive bladder. Int Urogynecol J 24 : 1065─1072, 2013

14） Kim JC, Park EY, Seo SI, et al : Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J Urol 175 : 1773─1776, 2006

15） Sacco E and Bientinesi R : Innovative pharmacotherapies for women with overactive bladder : where are we now and what is in the pipeline? Int Urogynecol J 26 : 629─640, 2015

16） Tyagi P, Barclay D, Zamora R, et al : Urine cytokines suggest an inflammatory response in the overactive bladder : a pilot study. Int Urol Nephrol 42 : 629─635, 2010

17） Tyagi P, Tyagi V, Qu X, et al : Association of inflammaging（inflammation＋aging）with higher prevalence of OAB in elderly population. Int Urol Nephrol 46 : 871─877, 2014

18） Ghoniem G, Faruqui N, Elmissiry M, et al : Differential profile analysis of urinary cytokines in patients with overactive bladder. Int Urogynecol J 22 : 953─961, 2011

19） Nomiya M, Sagawa K, Yazaki J, et al : Increased bladder activity is associated with elevated oxidative stress markers and proinflammatory cytokines in a rat model of atherosclerosis-induced chronic bladder ischemia. Neurourol Urodyn 31 : 185─189, 2012

20） Yokoyama T, Shimizu S, Fukumoto K, et al : Correlation of urinary oxidant stress marker level with the response of antimuscarinic therapy in patients with female overactive bladder. J Urol Supple 189 : 1850, 2013